Relationship between coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance and serum eicosapentaenoic acid

Table 2 CMR findings

	All patients	High EPA group	Low EPA group	* P value
	(n = 127)	(n = 64)	(n = 63)
Cine CMR
LVEDVI, mL/m²	73.9 ± 24.9	71.7 ± 21.8	76.1 ± 27.7	0.33
LVESVI, mL/m²	33.2 ± 19.9	31.0 ± 19.1	35.4 ± 20.7	0.21
LVSVI, mL/m²	40.8 ± 10.5	40.8 ± 8.6	40.8 ± 12.3	0.98
LVEF, %	57.1 ± 12.1	58.9 ± 11.7	55.3 ± 16.9	0.094
LV mass index, g/m²	56.3 ± 16.9	57.8 ± 17.0	54.8 ± 16.9	0.32
Late Gadolinium enhanced CMR
Presence of LGE	66 (52%)	32 (50%)	34 (54%)	0.65
LGE (%)	10.6 ± 14.2	9.0 ± 13.1	12.2 ± 15.2	0.21

Values are presented as mean ± standard deviation (SD).
* P value represents significance of difference between low EPA group and high EPA group.
EPA, eicosapentaenoic acid; CMR, cardiovascular magnetic resonance; LV, left ventricle; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; SVI, stroke volume index; EF, ejection fraction; LGE, late gadolinium enhancement.

ISSN: 1532-429X